Meanwhile, by using Cox regression analysis combined with KM survival analysis, we demonstrated that a high CD101 level served as an independent risk factor in predicting deteriorative OS for glioma patients, as also strengthened by multiple subgroup analyses stratifying patients by WHO grade, integrated diagnosis, age, IDH status, 1p/19q codeletion status, and primary therapy outcome. Here, CD101 is linked to central nervous system cancer.